The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...

The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...

Unless you have been living under a rock, you’ll know that anti-obesity GLP-1 drugs are the next big thing in pharma, with ...

A new study finds people who take weight-loss drugs also cut back on alcohol consumption. Researchers think the drugs could ...

Celebrity tweets about obesity and weight loss attract far more positive engagement than those from medical authorities, ...

After losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets ...

Learn more about the metabolic effects of liraglutide treatment in individuals with type 2 diabetes and obesity.

Health-care companies were more or less flat as traders picked winners and losers in the race to sell obesity drugs. Recent data from an Amgen obesity-drug trial only reinforced investors' impressions ...

The obesity prevalence continues to increase, with predictors of weight loss including type 2 diabetes status, high BMI, and older age.